Simulations Plus Partners With Major Drugmaker to Deploy AI Engine
Simulations Plus, Inc. (SLP) has secured a funded partnership with a large global pharmaceutical firm to deploy its artificial intelligence-enabled QSP engine, known as Turin. Under the agreement, the unnamed drugmaker will use the AI tool within an active therapeutic development program, with the potential to expand its use to additional programs in the future.
The deal represents paid demand for the company's Turin software and provides a hosted environment with support services. This structure is expected to increase revenue visibility and average selling prices by combining software with ongoing support. Partnering with a major, tier-1 pharmaceutical company also serves as a validation of the technology, which follows a previous collaboration with NVIDIA.
While the partnership is a positive step for commercializing its AI tools, investors will likely look for further details that have not yet been disclosed. Key factors to watch include the identity of the pharmaceutical partner, the total contract value, the duration of the agreement, and concrete evidence of the program expanding to other therapeutic areas.
Key points
- Simulations Plus secured a funded partnership with an unnamed global pharmaceutical company to use its Turin AI engine.
- The software will be deployed within an active therapeutic program, with potential expansion to additional programs.
- The agreement includes a hosted environment and technical support, which could boost average selling prices.
- The deal follows a prior collaboration with NVIDIA as part of the company's strategy to commercialize AI tools.
Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org
How we writeDisclaimerQuestions and answers
What AI tool is Simulations Plus partnering on?
The company is partnering with a global pharmaceutical firm to use Turin, its artificial intelligence-enabled QSP engine, within an active drug development program.
What are the financial terms of the Simulations Plus deal?
The specific contract value, agreement term, and the identity of the pharmaceutical partner have not been disclosed.
What does the partnership include besides software?
The deal includes a hosted environment and technical support services alongside the AI software, which can help increase average selling prices.